Silverio Tomao Selected Research

Oxaliplatin (Eloxatin)

3/2015	Continuous, low-dose capecitabine for patients with recurrent colorectal cancer.
10/2014	Docetaxel, oxaliplatin, and capecitabine combination chemotherapy for metastatic gastric cancer.
8/2013	Gemcitabine-oxaliplatin (GEMOX) as salvage treatment in pretreated epithelial ovarian cancer patients.
1/2012	Critical appraisal of bevacizumab in the treatment of metastatic colorectal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Silverio Tomao Research Topics

Disease

44	Neoplasms (Cancer) 05/2022 - 04/2006
37	Breast Neoplasms (Breast Cancer) 05/2022 - 07/2003
13	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 12/2009
12	Colorectal Neoplasms (Colorectal Cancer) 06/2021 - 09/2002
11	Neoplasm Metastasis (Metastasis) 09/2020 - 08/2011
6	Triple Negative Breast Neoplasms 01/2021 - 01/2015
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2020 - 01/2009
5	Carcinoma (Carcinomatosis) 09/2020 - 12/2009
5	Ovarian Epithelial Carcinoma 01/2016 - 12/2009
5	Infections 02/2010 - 05/2004
4	Uterine Cervical Neoplasms (Cancer of the Cervix) 06/2021 - 01/2014
4	Glioma (Gliomas) 01/2019 - 10/2012
4	Disease Progression 03/2015 - 09/2008
3	Renal Cell Carcinoma (Grawitz Tumor) 12/2021 - 10/2013
3	Pain (Aches) 07/2020 - 01/2013
3	Lung Neoplasms (Lung Cancer) 01/2020 - 01/2019
3	Stomach Neoplasms (Stomach Cancer) 10/2014 - 03/2008
3	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 11/2013 - 08/2009
3	Lymphoma (Lymphomas) 11/2013 - 02/2010
3	Metaplasia 07/2005 - 05/2004
2	Head and Neck Neoplasms (Head and Neck Cancer) 12/2021 - 09/2020
2	Squamous Cell Carcinoma of Head and Neck 12/2021 - 09/2020
2	Pathologic Complete Response 09/2020 - 01/2020
2	Hypersensitivity (Allergy) 01/2020 - 08/2013
2	Human Influenza (Influenza) 01/2020 - 10/2018
2	Prostatic Neoplasms (Prostate Cancer) 02/2019 - 01/2018
2	Brain Neoplasms (Brain Tumor) 01/2019 - 01/2009
2	Endometrial Neoplasms (Endometrial Cancer) 01/2018 - 11/2017
2	Carcinogenesis 01/2015 - 05/2004
2	Vomiting 11/2014 - 03/2008
2	Hypertension (High Blood Pressure) 10/2013 - 01/2009
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 07/2013 - 02/2010
2	Infertility (Sterility) 02/2013 - 10/2010
2	Adenocarcinoma 01/2011 - 03/2008
2	Diarrhea 01/2011 - 03/2008
1	Vulvar Neoplasms (Vulvar Cancer) 08/2021

Drug/Important Bio-Agent (IBA)

10	Biomarkers (Surrogate Marker)IBA 12/2021 - 09/2008
10	Bevacizumab (Avastin)FDA Link 09/2020 - 01/2012
9	PlatinumIBA 06/2021 - 12/2009
9	Hormones (Hormone)IBA 01/2019 - 08/2011
8	Paclitaxel (Taxol)FDA LinkGeneric 07/2019 - 05/2006
7	Biological ProductsIBA 08/2021 - 05/2012
6	Cisplatin (Platino)FDA LinkGeneric 06/2021 - 03/2008
6	Immune Checkpoint InhibitorsIBA 01/2021 - 10/2018
6	pertuzumabIBA 01/2021 - 01/2017
5	Capecitabine (Xeloda)FDA Link 06/2021 - 09/2008
5	Taxoids (Taxanes)IBA 09/2020 - 09/2008
5	Aromatase InhibitorsIBA 08/2013 - 07/2003
4	Cetuximab (Erbitux)FDA Link 12/2021 - 02/2009
4	Monoclonal AntibodiesIBA 12/2021 - 01/2012
4	Pharmaceutical PreparationsIBA 01/2021 - 12/2009
4	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2021 - 01/2016
4	Estrogen ReceptorsIBA 01/2021 - 01/2008
4	AnthracyclinesIBA 09/2020 - 09/2008
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 07/2014
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2019 - 10/2012
4	ErbB Receptors (EGF Receptor)IBA 01/2019 - 01/2011
4	Phenobarbital (Luminal)FDA Link 01/2019 - 01/2015
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 03/2015 - 01/2012
4	Fertility AgentsIBA 09/2014 - 02/2013
4	Angiogenesis InhibitorsIBA 01/2014 - 01/2009
3	Tyrosine Kinase InhibitorsIBA 01/2021 - 10/2013
3	Ado-Trastuzumab EmtansineIBA 01/2021 - 01/2017
3	Progesterone Receptors (Progesterone Receptor)IBA 01/2021 - 01/2015
3	human ERBB2 proteinIBA 01/2021 - 01/2015
3	Trastuzumab (Herceptin)FDA Link 12/2020 - 04/2016
3	exemestane (Aromasin)FDA Link 01/2019 - 07/2003
2	DNA (Deoxyribonucleic Acid)IBA 04/2021 - 01/2020
2	olaparibIBA 01/2021 - 01/2016
2	eribulin FDA Link 01/2021 - 01/2019
2	LigandsIBA 09/2020 - 11/2017
2	Estrogens (Estrogen)FDA Link 01/2020 - 01/2013
2	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2020 - 10/2018
2	Histones (Histone)IBA 01/2019 - 07/2014
2	taxaneIBA 01/2019 - 12/2009
2	Antineoplastic Agents (Antineoplastics)IBA 01/2019 - 01/2009
2	Everolimus FDA Link 01/2019 - 01/2017
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2016 - 01/2011
2	Irinotecan (Camptosar)FDA LinkGeneric 03/2015 - 01/2012
2	Fluorouracil (Carac)FDA LinkGeneric 10/2014 - 03/2008
2	Gemcitabine FDA Link 08/2013 - 05/2006
2	Letrozole (Femara)FDA LinkGeneric 08/2013 - 07/2003
2	Cytotoxins (Cytolysins)IBA 12/2009 - 01/2009
2	Pemetrexed (MTA)FDA Link 12/2009 - 01/2009
2	Epirubicin (Ellence)FDA LinkGeneric 03/2008 - 02/2007
2	UreaseIBA 07/2005 - 05/2005
2	beta CateninIBA 07/2005 - 05/2005
2	Cadherins (E-Cadherin)IBA 05/2005 - 05/2004
1	Cyclin-Dependent Kinase 4IBA 05/2022
1	talazoparibIBA 01/2021

Therapy/Procedure

48	Therapeutics 05/2022 - 01/2008
32	Drug Therapy (Chemotherapy) 12/2021 - 02/2007
7	Immunotherapy 05/2022 - 03/2014
7	Radiotherapy 06/2021 - 07/2012
3	Adjuvant Chemotherapy 10/2013 - 03/2008
2	Castration 02/2019 - 01/2018
2	Cytoreduction Surgical Procedures 01/2016 - 12/2009
1	Immunomodulation 05/2022
1	Nephrectomy 12/2021
1	Drug Tapering 01/2021